YasminAbazaMD

PubMed

• Treatment approach and outcomes of patients with accelerated/blast-phase myeloproliferative neoplasms in the current era.
  Anand A Patel, James J Yoon, Hannah Johnston, Marta B Davidson, Rory M Shallis, Evan C Chen, Madelyn Burkart, Timothy S Oh, Sunil Girish Iyer, Ellen Madarang, Chandras...> ;Blood Advances. 2024 May 13
• Advancements and Challenges in the Treatment of AML.
  Yasmin Abaza, Christine McMahon, Jacqueline S Garcia> ;American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting. 2024 Apr 1
• Clinical outcomes of hypomethylating agents plus Venetoclax as frontline treatment in patients 75 years and older with acute myeloid leukemia: Real-world data from eig...
  Yasmin Abaza, Eric S Winer, Guru Subramanian Guru Murthy, Rory M Shallis, Andrew H Matthews, Talha Badar, Emily M Geramita, Vamsi K Kota, Alok Swaroop, Peter Doukas, D...> ;American Journal of Hematology. 2024 Apr 1
• Clinical implications of additional chromosomal abnormalities in adult acute myeloid leukemia with inv (16)/t(16;16)/CBFB::MYH11.
  Juehua Gao, Lucas Santana-Santos, Lucy Fu, Emily Alvey, Qing Chen, Kristy Wolniak, Zongjun Xia, Barina Aqil, Amir Behdad, Peng Ji, Madina Sukhanova, Yasmin Abaza, Jess...> ;European Journal of Haematology. 2024 Jun 1
• Comparing venetoclax in combination with hypomethylating agents to hypomethylating agent-based therapies for treatment naive TP53-mutated acute myeloid leukemia: resul...
  Talha Badar, Ahmad Nanaa, Ehab Atallah, Rory M Shallis, Sacchi de Camargo Correia Guilherme, Aaron D Goldberg, Antoine N Saliba, Anand Patel, Jan P Bewersdorf, Adam S ...> ;Blood Cancer Journal. 2024 Feb 20
• Aspacytarabine for the treatment of patients with AML unfit for intensive chemotherapy: a phase 2 study.
  Altman, J., Zuckerman, T., Koprivnikar, J., McCloskey, J., Kota, V., Keng, M., Frankfurt, O., Abaza, Y., Bixby, D., Emadi, A., Burch, M., Bhatnagar, B., Luger, S., Per...> ;Blood Advances. 2023 Dec 26
• Novel Therapies in Myelodysplastic Syndrome: Where Do Venetoclax and Isocitrate Dehydrogenase Inhibitors Fit in?
  Yasmin Abaza, Anand Ashwin Patel> ;Cancer Journal. 2023 May 17
• 12 citations
  Survival of TP53-mutated acute myeloid leukemia patients receiving allogeneic stem cell transplantation after first induction or salvage therapy: results from the Cons...
  Talha Badar, Ehab Atallah, Rory Shallis, Antoine N Saliba, Anand Patel, Jan P Bewersdorf, Justin Grenet, Maximilian Stahl, Adam Duvall, Madelyn Burkart, Neil Palmisian...> ;Leukemia. 2023 Apr 1
• 4 citations
  The Impact of Mutation of Myelodysplasia-Related Genes in De Novo Acute Myeloid Leukemia CarryingMutation.
  Yi Wang, Andres E Quesada, Zhuang Zuo, L Jeffrey Medeiros, C Cameron Yin, Shaoying Li, Jie Xu, Gautam Borthakur, Yisheng Li, Chao Yang, Yasmin Abaza, Juehua Gao, Xinya...> ;Cancers. 2022 Dec 29
• 6 citations
  Bone marrow-confined IL-6 signaling mediates the progression of myelodysplastic syndromes to acute myeloid leukemia.
  Yang Mei, Kehan Ren, Yijie Liu, Annabel Ma, Zongjun Xia, Xu Han, Ermin Li, Hamza Tariq, Haiyan Bao, Xinshu Xie, Cheng Zou, Dingxiao Zhang, Zhaofeng Li, Lili Dong, Amit...> ;The Journal of Clinical Investigation. 2022 Sep 1
• 1 citations
  Advances in the pharmacological management of acute myeloid leukemia in adults.
  Yazan Numan, Yasmin Abaza, Jessica K Altman, Leonidas C Platanias> ;Expert Opinion on Pharmacotherapy. 2022 Sep 1
• 21 citations
  Immune Checkpoint Inhibition in Acute Myeloid Leukemia and Myelodysplastic Syndromes.
  Yasmin Abaza, Amer M Zeidan> ;Cells. 2022 Jul 20
• 25 citations
  Outcomes of TP53-mutated AML with evolving frontline therapies: Impact of allogeneic stem cell transplantation on survival.
  Talha Badar, Ehab Atallah, Rory M Shallis, Aaron D Goldberg, Anand Patel, Yasmin Abaza, Jan P Bewersdorf, Antoine N Saliba, Guilherme Sacchi De Camargo Correia, Guru M...> ;American Journal of Hematology. 2022 Jul 1
• 7 citations
  Monoclonal Antibodies in Acute Myeloid Leukemia-Are We There Yet?
  Yasmin Abaza, Amir T Fathi> ;Cancer Journal. 2022 Jan 24
• 26 citations
  Phase I/II study of dasatinib in combination with decitabine in patients with accelerated or blast phase chronic myeloid leukemia.
  Yasmin Abaza, Hagop M. Kantarjian, Yasmin Alwash, Gautam Borthakur, Richard E. Champlin, Tapan M. Kadia, Guillermo Garcia-Manero, Naval Daver, Farhad Ravandi, Srdan Ve...> ;American Journal of Hematology. 2020 Nov 1
• 44 citations
  Pracinostat plus azacitidine in older patients with newly diagnosed acute myeloid leukemia: results of a phase 2 study
  Guillermo Garcia-Manero, Yasmin Abaza, Koichi Takahashi, Bruno C. Medeiros, Martha Arellano, Samer K. Khaled, Mrinal M. Patnaik, Olatoyosi Odenike, Hamid Sayar, Mohan ...> ;Blood Advances. 2019 Feb 26
• 8 citations
  Phase I study of ruxolitinib in previously treated patients with low or intermediate-1 risk myelodysplastic syndrome with evidence of NF-kB activation.
  Yasmin Abaza, Juliana E. Hidalgo-Lopez, Srdan Verstovsek, Elias Jabbour, Farhad Ravandi, Gautam Borthakur, Zeev Estrov, Yesid Alvarado, Jan A. Burger, Heather Schneide...> ;Leukemia Research. 2018 Sep 14
• Prognostic significance of hyperdiploidy in adult acute myeloid leukemia
  Yasmin Abaza, Jorge E. Cortes, Farhad Ravandi, Tapan M. Kadia, Guillermo Garcia-Manero, Naveen Pemmaraju, Aditya Shetty, Sherry Pierce, Wei Qiao, Hagop M. Kantarjian, ...> ;American Journal of Hematology. 2018 Sep 9
• 63 citations
  Hyper-CVAD plus nelarabine in newly diagnosed adult T-cell acute lymphoblastic leukemia and T-lymphoblastic lymphoma.
  Yasmin Abaza, Hagop M. Kantarjian, Stefan Faderl, Elias Jabbour, Nitin Jain, Deborah A. Thomas, Tapan M. Kadia, Gautam Borthakur, Joseph D. Khoury, Jan A. Burger, Will...> ;American Journal of Hematology. 2018 Jan 1
• 37 citations
  Phase 1 dose escalation multicenter trial of pracinostat alone and in combination with azacitidine in patients with advanced hematologic malignancies
  Yasmin Abaza, Tapan M. Kadia, Elias J. Jabbour, Marina Konopleva, Gautam Borthakur, Alessandra Ferrajoli, Zeev Estrov, William G. Wierda, Ana Alfonso, Toh Han Chong, C...> ;Cancer. 2017 Dec 15
• 64 citations
  Estrogen Replacement Reduces Risk and Increases Survival Times of Women With Hepatocellular Carcinoma
  Manal Hassan, Gehan Botrus, Reham Abdel-Wahab, Robert A. Wolff, Donghui Li, David J. Tweardy, Alexandria T. Phan, Ernest T. Hawk, Milind Javle, Ju Seog Lee, Harrys A. ...> ;Clinical Gastroenterology and Hepatology. 2017 Nov 1
• 11 citations
  Primary autoimmune myelofibrosis: a case report and review of the literature.
  Yasmin Abaza, C. Cameron Yin, Carlos E. Bueso-Ramos, Sa A. Wang, Srdan Verstovsek> ;International Journal of Hematology. 2017 Apr 1
• 2 citations
  A case of lymphocytic variant hypereosinophilic syndrome with sub-diagnostic systemic mastocytosis.
  Preetesh Jain, Sa A. Wang, C. Cameron Yin, Yasmin Abaza, Srdan Verstovsek, Zeev Estrov> ;Blood Research. 2017 Mar 27
• 75 citations
  Phase 2, randomized, double‐blind study of pracinostat in combination with azacitidine in patients with untreated, higher‐risk myelodysplastic syndromes
  Guillermo Garcia-Manero, Guillermo Montalban-Bravo, Jesus G. Berdeja, Yasmin Abaza, Elias J. Jabbour, James Essell, Roger M. Lyons, Farhad Ravandi, Michael B. Maris, B...> ;Cancer. 2017 Mar 15
• 180 citations
  Long-term outcome of acute promyelocytic leukemia treated with all- trans-retinoic acid, arsenic trioxide, and gemtuzumab
  Yasmin Abaza, Hagop M. Kantarjian, Guillermo Garcia-Manero, Elihu H. Estey, Gautam Borthakur, Elias Jabbour, Stefan Faderl, Susan O'Brien, William G. Wierda, Sherry Pi...> ;Blood. 2017 Mar 9
• Join now to see all